Cargando…

Current relevance of hypoxia in head and neck cancer

Head and Neck cancer (HNC) is a complex mix of cancers and one of the more common cancers with a relatively poor prognosis. One of the factors that may assist us in predicting survival and allow us to adjust our treatment strategies is the presence of tumor hypoxia. In this overview we aim to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bredell, Marius G., Ernst, Jutta, El-Kochairi, Ilhem, Dahlem, Yuliya, Ikenberg, Kristian, Schumann, Desiree M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226620/ https://www.ncbi.nlm.nih.gov/pubmed/27434126 http://dx.doi.org/10.18632/oncotarget.9549

Ejemplares similares

Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue
por: Ernst, Jutta, et al.
Publicado: (2016)

Head and Neck Cancer in the Elderly: A Retrospective Study over 10 Years (1999 - 2008)
por: Kruse, Astrid L, et al.
Publicado: (2010)

Evaluation of the pectoralis major flap for reconstructive head and neck surgery
por: Kruse, Astrid L, et al.
Publicado: (2011)

IMRT/VMAT for malignancies in the head-and-neck region: Outcome in patients aged 80+
por: Brown, Michelle L., et al.
Publicado: (2016)

Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma
por: Besic Gyenge, Emina, et al.
Publicado: (2011)

Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer
por: Codony, Victoria L., et al.
Publicado: (2021)

Late term tolerance in head neck cancer patients irradiated in the IMRT era
por: Studer, Gabriela, et al.
Publicado: (2013)

Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto’s thyroiditis and ophthalmopathy or isolated upper eyelid retraction
por: Wall, Jack R, et al.
Publicado: (2014)

Beneficial effects of combinatorial micronutrition on body fat and atherosclerosis in mice
por: El Kochairi, Ilhem, et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Expressional analysis of disease-relevant signalling-pathways in primary tumours and metastasis of head and neck cancers
por: Goesswein, Dorothee, et al.
Publicado: (2018)

Immune-relevant aspects of murine models of head and neck cancer
por: Rossa, Carlos, et al.
Publicado: (2019)

Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer - preliminary experience
por: Bredell, Marius G
Publicado: (2010)

Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes
por: Serrano-Marco, Lucía, et al.
Publicado: (2011)

CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models
por: Huizing, Fokko J., et al.
Publicado: (2019)

Current strategies in radiotherapy of head and neck cancer
por: Pütz, M., et al.
Publicado: (2012)

Current Challenges in Head and Neck Cancer Management
por: Starzyńska, Anna, et al.
Publicado: (2022)

Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy
por: Bittner, Martin-Immanuel, et al.
Publicado: (2013)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review
por: Hildingsson, Sofia, et al.
Publicado: (2022)

Expression of hypoxia-related markers in inflammatory myofibroblastic tumors of the head and neck
por: Wang, Kui-Rong, et al.
Publicado: (2013)

Current clinical immunotherapeutic approaches for head and neck cancer
por: Soto Chervin, Carolina, et al.
Publicado: (2016)

Immunotherapy of Head and Neck Cancer: Current and Future Considerations
por: Rapidis, Alexander D., et al.
Publicado: (2009)

Current evidence on the burden of head and neck cancers in Nigeria
por: da Lilly-Tariah, Opubo B, et al.
Publicado: (2009)

Vascular anomalies of the head and neck: current overview
por: Lee, Jeong Woo, et al.
Publicado: (2018)

Current topics and management of head and neck sarcomas
por: Kobayashi, Kenya, et al.
Publicado: (2023)

The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation
por: Rühle, Alexander, et al.
Publicado: (2022)

Hypoxia in Head and Neck Cancer in Theory and Practice: A PET-Based Imaging Approach
por: Marcu, Loredana G., et al.
Publicado: (2014)

Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines
por: Wohlleben, Gisela, et al.
Publicado: (2015)

Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck
por: Kunder, Shreya, et al.
Publicado: (2021)

Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers
por: Dhakal, Aastha, et al.
Publicado: (2022)

Aesthetic Units and Zones of Adherence: Relevance to Surgical Planning in the Head and Neck
por: Kirwan, Laurence
Publicado: (2023)

Tongue cancer in young patients: case report of a 26-year-old patient
por: Credé, Aleksandra, et al.
Publicado: (2012)

Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma
por: Sun, Zhi-Jun, et al.
Publicado: (2016)

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck
por: Stegeman, Hanneke, et al.
Publicado: (2012)

Nutritional interventions in patients with head and neck cancer undergoing chemoradiotherapy: Current practice at the Dutch Head and Neck Oncology centres
por: Kok, Annemieke, et al.
Publicado: (2021)

The current status of oncolytic viral therapy for head and neck cancer
por: Old, Matthew O., et al.
Publicado: (2016)

Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
por: Qian, Jack M., et al.
Publicado: (2021)

Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy
por: Marcu, Loredana G., et al.
Publicado: (2021)

Current Insights and Progress in the Clinical Management of Head and Neck Cancer
por: Amaral, Mariana Neves, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sihble9am3uo6643r1h00f4jdr